Table 1.
The table shows the assessment and follow-up schedule
Observation/Investigation | Screening/baseline assessments | Randomisation | 12 weeks of study participation | |
Hospital based pulmonary rehab | Follow-up phase of homebased exercises | |||
End of 6 weeks of PR | End of 6 weeks of home exercises | |||
Written informed consent | x | x | ||
Demographics | x | x | ||
Medical history | x | x | ||
Clinical exam | x | x | ||
Chest X-ray | x | |||
Spirometry | x | |||
MRC dyspnoea grade | x | x | x | |
Assess symptoms | x | x | x | |
Incremental Shuttle Walk Test | x | x | x | |
Endurance Shuttle Walk Test | x | x | x | |
Borg breathlessness scale | x | x | x | |
Mid Upper Arm Circumference | x | x | x | |
Sit-to-stand time | x | x | x | |
COPD Assessment Test | x | x | x | |
Clinical COPD Questionnaire | x | x | x | |
Patient Health Questionnaire | x | x | x | |
HADS | x | x | x | |
WPAI | x | x | x | |
Physical Activity (Actigraph monitor) | x | x | x | |
Cost/benefit analysis | x | x | x | |
EQ-5D-5L Questionnaire | x | x | x |
COPD, chronic obstructive pulmonary disease; EQ-5D-5L, European Quality of Life 5-Dimensions; HADS, Hospital Anxiety and Depression Scale; MRC, Medical Research Council; WPAI, Work Productivity and Activity Impairment.